| VHL protein‐interacting deubiquitinating enzyme 2 deubiquitinates and stabilizes HIF‐1α Z Li, D Wang, EM Messing, G Wu EMBO reports 6 (4), 373-378, 2005 | 241 | 2005 |
| Activation of Ras/Erk pathway by a novel MET-interacting protein RanBPM D Wang, Z Li, EM Messing, G Wu Journal of Biological Chemistry 277 (39), 36216-36222, 2002 | 233 | 2002 |
| Ubiquitination of a novel deubiquitinating enzyme requires direct binding to von Hippel-Lindau tumor suppressor protein Z Li, X Na, D Wang, SR Schoen, EM Messing, G Wu Journal of Biological Chemistry 277 (7), 4656-4662, 2002 | 199 | 2002 |
| Deubiquitination of type 2 iodothyronine deiodinase by von Hippel–Lindau protein–interacting deubiquitinating enzymes regulates thyroid hormone activation C Curcio-Morelli, AM Zavacki, M Christofollete, B Gereben, ... The Journal of clinical investigation 112 (2), 189-196, 2003 | 156 | 2003 |
| Identification of a deubiquitinating enzyme subfamily as substrates of the von Hippel–Lindau tumor suppressor Z Li, D Wang, X Na, SR Schoen, EM Messing, G Wu Biochemical and biophysical research communications 294 (3), 700-709, 2002 | 146 | 2002 |
| Prevalence and genotype distribution of HPV infection in China: analysis of 51,345 HPV genotyping results from China's largest CAP certified laboratory Z Zeng, H Yang, Z Li, X He, CC Griffith, X Chen, X Guo, B Zheng, S Wu, ... Journal of Cancer 7 (9), 1037, 2016 | 128 | 2016 |
| Chemically diverse toxicants converge on Fyn and c-Cbl to disrupt precursor cell function Z Li, T Dong, C Pröschel, M Noble PLoS biology 5 (2), e35, 2007 | 111 | 2007 |
| The VHL protein recruits a novel KRAB‐A domain protein to repress HIF‐1α transcriptional activity Z Li, D Wang, X Na, SR Schoen, EM Messing, G Wu The EMBO journal, 2003 | 103 | 2003 |
| The immune microenvironment in hormone Receptor–Positive breast cancer before and after preoperative chemotherapy AG Waks, DG Stover, JL Guerriero, D Dillon, WT Barry, E Gjini, C Hartl, ... Clinical Cancer Research 25 (15), 4644-4655, 2019 | 86 | 2019 |
| HER2 intratumoral heterogeneity is independently associated with incomplete response to anti-HER2 neoadjuvant chemotherapy in HER2-positive breast carcinoma Y Hou, H Nitta, L Wei, PM Banks, B Portier, AV Parwani, Z Li Breast cancer research and treatment 166, 447-457, 2017 | 85 | 2017 |
| PD‐L1 expression and CD8‐positive T cells are associated with favorable survival in HER2‐positive invasive breast cancer Y Hou, H Nitta, L Wei, PM Banks, M Lustberg, R Wesolowski, ... The breast journal 24 (6), 911-919, 2018 | 81 | 2018 |
| Clinical significance of atypical glandular cells in Pap tests: An analysis of more than 3000 cases at a large academic women's center D Pradhan, Z Li, R Ocque, S Patadji, C Zhao Cancer cytopathology 124 (8), 589-595, 2016 | 70 | 2016 |
| The microcystic, elongated, and fragmented (MELF) pattern of invasion: a single institution report of 464 consecutive FIGO grade 1 endometrial endometrioid adenocarcinomas AS Joehlin-Price, KE McHugh, JA Stephens, Z Li, FJ Backes, DE Cohn, ... The American journal of surgical pathology 41 (1), 49-55, 2017 | 68 | 2017 |
| Contemporary whole slide imaging devices and their applications within the modern pathology department: a selected hardware review A Patel, UGJ Balis, J Cheng, Z Li, G Lujan, DS McClintock, L Pantanowitz, ... Journal of Pathology Informatics 12 (1), 50, 2021 | 66 | 2021 |
| Prior high-risk human papillomavirus testing and Papanicolaou test results of 70 invasive cervical carcinomas diagnosed in 2012: results of a retrospective multicenter study C Zhao, Z Li, R Nayar, AW Levi, BA Winkler, AT Moriarty, GA Barkan, ... Archives of Pathology and Laboratory Medicine 139 (2), 184-188, 2015 | 63 | 2015 |
| The SPRY domain-containing SOCS box protein 1 (SSB-1) interacts with MET and enhances the hepatocyte growth factor-induced Erk-Elk-1-serum response element pathway D Wang, Z Li, EM Messing, G Wu Journal of Biological Chemistry 280 (16), 16393-16401, 2005 | 61 | 2005 |
| TRPS1, GATA3, and SOX10 expression in triple-negative breast carcinoma EC Yoon, G Wang, B Parkinson, L Huo, Y Peng, J Wang, T Salisbury, ... Human pathology 125, 97-107, 2022 | 58 | 2022 |
| Digital pathology initiatives and experience of a large academic institution during the coronavirus disease 2019 (COVID-19) pandemic GM Lujan, J Savage, A Shana'ah, M Yearsley, D Thomas, P Allenby, ... Archives of pathology & laboratory medicine 145 (9), 1051-1061, 2021 | 53 | 2021 |
| Programmed death ligand 1 expression among 700 consecutive endometrial cancers: strong association with mismatch repair protein deficiency Z Li, AS Joehlin-Price, J Rhoades, M Ayoola-Adeola, K Miller, AV Parwani, ... International Journal of Gynecologic Cancer 28 (1), 2018 | 52 | 2018 |
| Evaluation of immune reaction and PD-L1 expression using multiplex immunohistochemistry in HER2-positive breast cancer: the association with response to anti-HER2 neoadjuvant … Y Hou, H Nitta, L Wei, PM Banks, AV Parwani, Z Li Clinical breast cancer 18 (2), e237-e244, 2018 | 49 | 2018 |
